Nurix Therapeutics, Inc. · NASDAQ:NRIX

Vestal Point Capital, LP reported a 6.30% stake in Nurix Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Vestal Point Capital, LP reported a 6.30% stake in Nurix Therapeutics, Inc., 6,500,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
6.30%
Shares
6,500,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Vestal Point Capital, LP6.30%6,500,000
Ryan Wilder6.30%6,500,000

Source

View original at SEC

Related